Capricor Therapeutics Inc (CAPR)
US$ 10.86-2.34%
Price Chart
Key Statistics
Market Cap
$ 464.85M
P/E Ratio
0.00
Revenue (TTM)
$ 17.36M
Volume
1.92M
52W High
$ 23.40
52W Low
$ 3.52
Dividend Yield
0.00%
Beta
0.85
Technicals
50-Day MA
10.5922
200-Day MA
13.6748
52 Week High
23.4
52 Week Low
3.52
About CAPR
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and.
Employees
160
Headquarters
San Diego, CA
CEO
Dr. Frank Isaac Litvack FACC, M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg